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INTRODUCTION
Disuse osteoporosis is defined as localized or gen-
eralized bone loss resulting from reduction of mechani-
cal stress on bones. Low or loss of mechanical stress
on bones induces acceleration of osteoclast-mediated
bone resorption and inhibition of osteoblast-mediated
bone formation leading to bone loss. Therapeutic bed
rest, prolonged voluntary bed rest (1), localized im-
mobilization due to paraplegia or paraparesis due
to spinal cord injury (2), hemiplegia or hemiparesis
due to stroke (3) or application of a cast to treat
fractures (4) cause disuse osteoporosis.
The morphological characteristics of disuse osteoporosis
are a decrease in bone mineral density (BMD) and
thinning of cortical bone at the diaphysis, which re-
sult in a reduction of bone strength and an increase
risk of fractures. It takes a long time to recover from
disuse osteoporosis in spite of continuous and ag-
gressive treatment involving medication and reha-
bilitation. Hence, we have to keep in mind that there
are no treatments better than prophylaxis of disuse
osteoporosis. This review refers to the mechanism,
the diagnosis using imaging techniques and bone
metabolism markers, and treatment and prophylaxis
of disuse osteoporosis.
Mechanism of disuse osteoporosis
Mechanical stress on bone is one of the determi-
nants of bone morphology, BMD and bone strength.
Therefore, disuse accelerates bone resorption, espe-
cially of cancellous bone, and consequently bone
becomes atrophic and fragile. Osteocytes embedded
in the bone matrix respond to mechanical load and
changes of bone metabolism (5-7). The gap junction
of the long processes of osteocytes plays an impor-
tant role in transmitting mechanical load (8) through
intracellular signal transmitters (cAMP, cGMP) (9)
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and extracellular signal transmitters (PGE2, IGF-I,
IGF-II, TGF-β) (10) to induce bone formation by
osteoblasts, inhibition of bone resorption by osteoclasts,
or a combination of the two (Fig. 1).
Bones with a high proportion of cancellous bone
are at the highest risk of disuse osteoporosis. The
pattern of bone loss in different regions varies, and
the difference may be ascribable to a site-specific
cortical to trabecular bone ratio. Einhorn (11) showed
that the relative content of trabecular bone varied
among the different parts of the skeleton, and that
the content of trabecular bone was 66-90% in the
vertebrae, 50% in the hip (intertrochanteric region),
25% in the hip (femoral neck), 25% in the distal ra-
dius, 1% in the mid-radius, and 5% in the femoral
shaft. As for bone metabolism, the trabecular bone
is approximately eight times as active as cortical
bone, because the surface of trabecular bone is larger
than that of cortical bone, and its response to meta-
bolic changes is faster (12). Recumbency for one
week induced a 1% decrease of bone mineral con-
tent of the vertebral body (13). Based on this fact,
changes resulting from lowmechanical stress on bone
are logically more prominent in trabecular bone than
in cortical bone.
As for differences of bone metabolism during bed
rest or under a microgravity environment, Shigematsu
et al. (14) showed that under microgravity environ-
ment, there was a significant difference in disuse
bone atrophy between weight-bearing bones and
non-weight-bearing bones, and that undermicrogravity
environment in the space, the BMD of the lumbar
spine decreased , in contrast, the BMD of the skull
increased. Moreover, 17 weeks of continuous bed
rest induced a decrease of BMD of weight-bearing
bones and an increase of BMD of non-weight-bearing
bones, such as skull (15). The mechanisms by which
bone mineral metabolism varies during bed rest
and in a microgravity environment have not been
clarified.
Assessment of disuse osteoporosis
Characteristic physical findings of disuse osteoporosis
Most cases of disuse osteoporosis of upper and
lower extremities are associated with muscle atro-
phy and weakness of the muscles attached to the
atrophied bone. If the mass of the skeletal muscle
and muscle strength are diminished, mechanical stress
on bone will be reduced, bone resorption and bone
formation will be inhibited, resulting in bone atrophy,
disuse osteoporosis. Therefore, assessment of muscle
atrophy and muscle weakness allows us to predict
the occurrence of disuse osteoporosis.
Circumference of upper arm (COUA), circumfer-
ence of forearm (COFA), circumference of thigh
(COT) and circumference of lower leg (COLL) are
measured to assess muscle atrophy. More than 1 cm
difference between the right side and left side in
COUA, COFA, COT and COLL would indicate mus-
Fig. 1 Mechanism of transduction of mechanical stress to bone. The gap junction of the long processes of osteocytes plays an im-
portant role in transmission of mechanical stress through intracellular signal transmitters (cAMP, cGMP) and extracellular signal
transmitters (PGE2, IGF-I, IGF-II, TGF-β), inducing thereby bone formation by osteoblasts and bone resorption by osteoclasts, or
both.
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cle atrophy of those with a smaller circumference.
Table 1 shows manual muscle testing. If muscle
strength is significant different between the right side
and left side, disuse osteoporosis of the side with lower
muscle strength should be suspected.
Plain X-ray film
1. Tubular bone
A plain X-ray film reveals important features of
disuse osteoporosis affecting tubular bones, thinning
of cortices, increased radiolucency and rarefication
of bone trabeculae. There are 4 patterns of bone
resorption, subperiosteal, endosteal, intracortical and
trabecular bone resorption (16) (Fig. 2). Subperiosteal
bone resorption results from hyperparathyroidism.
Endosteal bone resorption is characteristic of senile
osteoporosis. Our previous study showed that im-
mobilization by sciatic neurectomy resulted in a
decrease of the periosteal circumference of bone,
whereas endosteal circumference did not change
(17). This fact suggested that immobilization induce
periosteal bone resorption by activating osteoclasts
in the periosteum.
The Singh Index (18) was introduced to classify
bone atrophy of the proximal end of the femur from
Grade I to VI according to the degree of bone resorp-
tion.
This score is useful to predict femoral neck frac-
ture in the patient with osteoporosis.
2. Spine
The radiographic manifestation of disuse osteoporosis
of the vertebral body include increased radiolucency,
framed appearance (picture framing), and stand out
vertical striation of the vertebral body. The criteria
of radiographic oseopenia was proposed by the Re-
search Group on Osteoporosis from the Japanese
Ministry of Health and Welfare ; this ranges from
Grade I to III according to the resorption of the
longitudinal trabeculae (Table 2) (19).
Dual energy X-ray absorptiometry
Dual energy X-ray absorptiometry (DXA) has been
used to measure total body and regional BMD, and
Table 1. Grading system of manual muscle test using Lovett
Method and Rehabilitation Treatment
Grade Lovett Method Rehabilitation Treatment
5/5 Normal (N) Resistive exercise
4/5 Good (G) Resistive exercise
3/5 Fair (F) Active exercise
2/5 Poor (P) Active assistive exercise
1/5 Trace (T) Passive exercise
Electrical stimulation
EMG biofeedback
0/5 Zero (Z) Passive exercise
Electrical stimulation
Fig. 2 Patterns of resorption of tubular bones.
(A) Normal, (B) Periosteal bone resorption, (C) Endosteal bone resorption, (D) Intracortical bone resorption, (E) Trabecular bone
resorption.
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soft tissue composition. DXA has proved to be of
diagnostic value in metabolic bone disease and has
become a useful tool to measure total body BMD
and soft tissue mass composition (20, 21). In previ-
ous studies dual photon absorptiometry (DPA)
with 153Gd was applied to measure total body BMD
and regional BMD (17). However, the coefficient of
variation (CV) for DXA for total body BMD and soft
tissue mass was 0.5% -1.0% (21), whereas the CV
for DPA for total body BMD was 1.0% -2.0% (22).
1. Brachial plexus injury
We measured BMD and soft tissue composition
in a patient with left sided brachial plexus injury using
DXA. The function of the left arm was severely im-
paired. The results showed that bone mineral con-
tent, BMD and lean mass of the injured arm were
lower than those of the intact arm, whereas fat mass,
% fat of the injured arm are higher than those of the
intact arm (Table 3).
2. Atraumatic vertebral fracture
We studied the characteristics of regional BMD and
soft tissue composition in patients with atraumatic
vertebral fractures using DXA. Regional BMD and
soft tissue mass were measured by DXA. Total body
BMD, BMDs of the lumbar spine, thoracic spine,
pelvis of the fracture group were significantly lower
than those of the non-fracture group (P<0.001). Fat
mass and lean mass of total body and respective
regions did not differ significantly between the two
groups. The results showed that the BMD of weight
bearing bones, except for bones of legs of the frac-
ture group, was significantly lower than that of the
non-fracture group (23). The results suggest that
immobilization resulting from atraumatic vertebral
fracture accelerates bone resorption of weight bear-
ing bones.
3. Osteoarthritis
Osteoarthritis (OA) is the most common disease
of joints. Clinical manifestations of OA are pain, swell-
ing and decreased range of motion. The most fre-
quently affected joint is the knee joint. As OA worsens,
the gait of the patient is disturbed and this may cause
loss of mechanical stress on the bones of the legs
with involved knee joint, which will in turn lead to
disuse osteoporosis.
We compared the BMD and soft tissue composi-
tion of legs between patients with OA of the knee
and controls matched for gender, age, body mass
index, and mean BMD of the 2nd to 4th lumbar
vertebrae. The results showed that BMD, bone min-
eral content and lean mass of leg with OA of the
knee were lower than those of the leg of controls.
These findings suggest that immobilization result-
ing from pain in the knee leads to low mechanical
stress on the bones of the leg with OA of knee, result-
ing in disuse osteoporosis of that leg (unpublished
data).
Computed tomography and biophysic evaluation
Yonezu et al . (17) studied the effects of immobi-
lization induced by sciatic neurectomy on the femur
of rats using peripheral quantitative computed tomog-
raphy (pQCT) and Fourier transform infrared spec-
troscopy (FTIR). Cortical bone mineral content, bone
area , and the periosteal circumference of the femo-
ral shaft measured by pQCT, were significantly smaller
than those of the control, whereas the cortical BMD
did not differ significantly. Cancellous bone mineral
Table 2. The criterion of radiographic osteopenia19)
Grade Radiographic appearance of the vertebral body
１
２
３
The longitudinal trabeculae are prominent
The longitudinal trabeculae are coarse
The longitudinal trabeculae are unclear
Table 3. Bone mineral content, bone mineral density, lean mass, fat mass, fat mass+bone mineral content, total weight, and %fat of
the arm in the injured side and the intact side, of a patient with brachial plexus injury, as determined by dual energy X-ray
absorptiometry.
Injured side Intact side injured/Intact
Bone mineral content (g)
Mone mineral density (cm2)
Lean mass (g)
Fat mass (g)
Lean mass+bone mineral content (g)
Total weight (g)
%Fat (%)
78.6
0.555
1,431.5
632.3
1,510.1
2,142.5
29.5
133.0
0.719
2,472.5
417.1
2,605.5
3,022.6
13.8
0.59
0.77
0.58
1.52
0.58
0.71
2.14
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content and BMD at the metaphysis of the femur
on the neurectomized side decreased significantly
compared with the control. These facts suggest that immo-
bilization induced by neurectomy inhibits periosteal
bone formation or accelerates bone resorption.
Quantitative assessment of macro-and microstructural
features may contribute to a more accurate estima-
tion of bone strength. The methods available for
quantitatively assessing the macrostructure include
(besides conventional radiographs) quantitative com-
puted tomography and volumetric quantitative com-
puted tomography.
To determine bone strength, quantitative analy-
sis of the trabecularmicrostructure bymicro-computed
tomography (muCT) and high-field proton nuclear
magnetic resonance (NMR) is more important than
that of trabecular macrostructure of bone by con-
ventional radiography.
High-field proton NMR is applied to analyze trabecular
microstructure quantitatively, which obtain high con-
trast between the marrow proton signal and the bone as
three-dimensional volumetric proton NMRmicroimaging
(24, 25). muCT is also a useful tool to analyze the
microstructure of bones. muCT is principally appli-
cable in vitro (26).
Markers of bone metabolism
1. Bed rest and microgravity environment
Bed rest induces disability of the central nervous
system, digestive system, respiratory system and cir-
culation system as well as of bones, leading to dis-
use syndrome. Therefore, disuse osteoporosis is one
of the symptoms of disuse syndrome. Bed rest for
12 weeks decreased BMD of the femoral neck. Among
bone metabolism markers, serum parathyroid hor-
mone (PTH) and 1,25-dihydroxyvitamin D decreased
within respective normal levels, whereas serum
osteocalcin (OC) and serum bone specific alkaline
phosphatase (BAP) did not change during bed rest. As
for markers of bone resorption, urinary hydroxyproline
(HP), urinary deoxypyridinoline (D-Pyr) and urinary
type I collagen cross-linked N-telopeptides (NTx)
increased with significant difference, however, after
ambulation, these markers tended to decrease with
time (27).
In order to clarify the effects of microgravity on
bone mineral metabolism, the markers of bone for-
mation and bone resorption were assessed during
6 degrees head-down tilt bed rest for 7 days. Serum
OC shows the earliest response of bone to head-down
tilt bed rest. Serum OC increased and remained el-
evated during bed rest, however, within 5 days of
reambulation, serum OC returned to pre-bed rest
values. Urinary Pyr, D-Pyr and HP increased promptly
after bed rest, which were paralleled by tartrate-resistant
acid phosphotase (TRAP) with significant increases.
Urinary HP, urinary Pyr and serum TRAP remained
high for 2 weeks after reambulation (28). Base on
these facts, osteoclast-mediated bone resorption
during head-down tilt bed rest was assumed to re-
main higher than that during no head-down tilt bed
rest. Furthermore, urinary Pyr and D-Pyr increased
40-50% of their respective pre-bed rest levels ; in
contrast, in a microgravity environment in the space,
these values increased twofold their respective val-
ues before space flight (29). There is a marked differ-
ence in the activity of osteoclasts betweenmicrogravity
and the 1G gravity environment on the earth.
2. Ischemic Cerebral Vascular Disease (Stroke)
The BMD of the upper and lower extremities on
the affected side decreases in patients with hemiplegia
(30, 31), and results in disuse osteoporosis. In the
acute phase of stroke, serum Pyr, serum procollagen
type I C-terminal telopeptide (ICTP) and serum
beta2-microglobulin increased (32). This fact sug-
gests that serum beta2-microglobulin may be a good
indicator of bone resorption in a patient with stroke.
In the chronic phase of stroke, bed rest for 30 to
180 days induced an increase in urinary Pyr, urinary
D-Pyr and serum ICTP. In contrast, serum BAP and
serum carboxyterminal propeptide of human type
I procollagen (PICP) remained at normal levels (33).
This result indicates that prolonged bed rest to treat
stroke affects bone resorption, not bone formation
A study done to clarify the effects of etidronate
on bone metabolism in patients with hemiplegia
showed that etidronate increased serum 1,25(OH)2D,
serum PTH and serum OC, whereas it decreased
serum ICTP and serum ionized Ca. These results
suggest that etidronate prevents bone loss by increas-
ing serum 1,25(OH)2D and decreasing (31).
3. Spinal cord injury
One of the complications of spinal cord injury is
disuse osteoporosis due to increased bone turnover.
A six-month longitudinal follow-up of bone metabo-
lism markers showed that urinary Pyr, urinary D-Pyr
and urinary NTx increased and reached to their re-
spective maximal levels by 10 to 16 weeks after in-
jury, whereas serum OC and serum BAP increased
only a little (34). Qadriplegia and paraplegia accel-
erates bone resorption compared with bone forma-
tion, increasing the risk of fractures. In the chron-
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ic phase of spinal cord injury, after mean time period
of 19 years from spinal cord injury, serum PICP,
serum BAP, serum OC, serum ICTP and urinary HP
showed no signs of acceleration of bone formation
nor of bone resorption (35). Bonemetabolismmarkers
in the chronic phase do not seem to be useful to assess
bone metabolism. In the acute phase of spinal cord
injury, intravenous injection of pamidronate inhibited
the increase of bone resorption markers and the con-
sequent decrease of BMD, suggesting it is effective
to treat disuse osteoporosis (36).
4. Autoimmune disease
Rheumatoid arthritis (RA) is a chronic polyarthritis
associated with gradual progressive development of
joint pain, swelling and destruction. RA is one of the
causes of secondary osteoporosis. If steroidal hor-
mones are administered to RA patients to alleviate a
pain of the involved joints, bone resorption will be
accelerated and the risk of fractures will increase
(37, 38). In the early stage of RA, bone atrophy is
obscured around the involved joints ; this is called
juxta-articular osteoporosis. In progressive RA, bone
atrophy tends to extend to other joints leading to
become generalized osteoporosis.
Kameyama et al. (39) showed that the mean level
of urinary Pyr and urinary D-Pyr were significantly
higher in RA patients than in healthy controls ; in
addition, the Pyr/D-Pyr ratio in the RA patients was
higher than that in normal control. Interestingly, uri-
nary Pyr increased as the Lansbury’s joint score in-
creased. Urinary Pyr may serve as an indicator of
the activitity of RA, because urinary Pyr includes a
lot of collagen type II. The decrease in lumbar BMD
significantly correlated with bone serumOCand serum
ICTP. In addition, the decrease of femoral neck BMD
correlated with only serumOC (40). Based on these
facts, measurement of serum OC and serum ICTP
may predict changes in BMD in the lumbar spine
and femoral neck .
Furumitsu et al. (41) measured synovial fluid (SF)
Pyr and SF D-Pyr to elucidate the major source of
pyridinium crosslinks in RA, and showed that the
levels of SF D-Pyr were significantly higher in pa-
tients with RA than in patients with osteoarthritis,
and that the levels of both SF Pyr and SF D-Pyr
showed a significantly positive correlation with levels
of SF interleukin 1beta or SF interleukin 6 in pa-
tients with RA. As stated in this study, the levels of
serum Pyr and serum D-Pyr were significantly higher
in patients with RA than in healthy controls. The
authors suggested that the increase of serum Pyr in
RA would derive mostly from involved joints and
that an increase of serum D-Pyr in RA may indicate
systemic bone resorption.
Ankylosing spondylitis (AS) is also causative of
disuse osteoporosis. AS is an inflammatory arthri-
tis of the spines, sacroiliac joints, hip joints and shoul-
der joints. Involvement of peripheral joints is less
common in AS. With progression of ankylosis of joints,
the activity of the patients decreases inducing disuse
bone atrophy and generalized osteoporosis. Yilmaz
et al. (42) showed that urinary Pyr and urinary D-Pyr
were higher in AS patients than in healthy controls.
In AS, osteoclasts are activated to resorb bone, where-
as the activity of osteoblasts remains normal .
5. Fracture
During treatment of fractures, disuse osteoporosis
is inevitable, because for conservative and opera-
tive treatment of fractures, a cast is applied to im-
mobilize the bones and joint and , thereby, stabilize
and fix the fracture.
In patients with hip fracture, serumOC at the time
of admission was 20% lower in the fractured women
than in healthy controls. In contrast, urinary Pyr
and urinary D-Pyr were significantly higher in the
fractured women than in healthy controls. Within 18
hours after hip fracture, serum OC did not change,
however, its value decreased with time until the
3rd postoperative day (43).
Ohnishi et al . (44) studied changes of bone me-
tabolism markers during healing of hip fracture in
patients with osteoporosis. The authors showed that
urinary Pyr, urinary D-Pyr and urinary type I colla-
gen cross-linked C-telopeptide (CTx) started to rise
from 1 week after operation, but they returned to the
respective initial values by week 24 after operation.
In contrast, serum OC increased week 8, and was
still high at week 24. These facts suggested that in
the early stage of hip fracture, bone resorption is
facilitated by acute osteonecrosis and bed rest, and
after that, bone formation is accelerated by callus
formation or increase in mechanical stress on bone.
Bone metabolism markers have become promis-
ing predictors of fractures. Women with both low
femoral BMD and high levels of bone resorption
markers (urinary CTx and urinary D-Pyr) are at a
greater risk of hip fractures. The odds ratio than
women with only low BMD or high level of bone
resorption markers were 4.8 and 4.1, respectively
(45). Moreover, Vergnaud et al. (46) showed that
high level of circulating undercarboxylated OC were
associated with a high risk of fracture, independently
S. Takata et al. Disuse Osteoporosis１５２
of femoral neck BMD, in elderly women.
Treatment and prophylaxis
Rehabilitation
1. Bed positioning
Prolonged bed rest produces profound changes
in muscles and bones, particularly of the lower limbs,
leading to disuse osteoporosis and decubiti. The sig-
nificant physiological changes induced by weight-
lessness are cephalic fluid shift, which lead to facial
edema, nasal congestion, increase of urinary flow,
decrease in creatinine excretion, decrease in lower
leg volume, and disuse atrophy of bone and skel-
etal muscles of upper and lower extremities (47).
To avoid cephalic fluid shift, the patients should be
maintained in a head-up position on the bed, except
while sleeping. To prevent decubiti during bed rest,
turning the patients with spinal cord injury and
stroke every two hours is recommended (48).
2. Therapeutic exercise
The main cause of disuse osteoporosis is loss or
reduction of mechanical stress on bones, which pro-
duces compressive and vertical loading onweight-bearing
bones, spine, pelvis and leg bones. Hence, to produce
mechanical stress, early weight bearing ambulation,
with or without crutches, is recommended. Further
more, disuse osteoporosis is always associated with
muscle atrophy and muscle weakness. Therefore,
therapeutic exercise is effective to increase not only
muscle volume but also BMD. Furthermore, thera-
peutic exercise increases or maintain the mobility
of joints and soft tissues, which results in an increase
of the microcirculation in skeletal muscles. An ad-
equate medical evaluation is essential before thera-
peutical exercise to prevent complications. Therapeu-
tic exercise is prescribed according tomuscle strength
evaluated by manual muscle test.
In RA treatment, therapeutic exercise should be
performed prudently to avoid injury of joint carti-
lage, because repeated and stressful joint motion
will contribute to further deteriorate the inflamma-
tion of joints. Motion of inflammatory joints should
be kept to a minimum during therapeutic exercise.
In order to strengthen bilateral biceps brachialis
muscles, isometric exercises are prescribed using
a beach ball resistance. If there are no cardiovascular
considerations, a 6-second maximum contraction,
twice daily, can be prescribed.
3. Electrical therapy
We stress that disuse osteoporosis is always as-
sociated with atrophy and weakness of the skeletal
muscles attached to the bone . Therefore, if muscle
strength and muscle mass can be recovered by electri-
cal therapy, electrical stimulation, disuse osteoporosis
must improve. As shown in table, electrical stimu-
lation should be applied to patients with poor (1/5)
or zero (0/5) muscle strength. Passive muscle con-
traction by electrical stimulation allows atrophied
bone to recover its BMD or BMC by accelerating
osteoblast-mediated bone formation or inhibiting
osteoclast-mediated bone resorption.
The most important condition of electrical stimu-
lation is the stimulation frequency. For electrical
stimulation, we should select a stimulation frequen-
cy at which the patient does not feel discomfort or
pain during stimulation. Furthermore, we have to
know the difference of energy metabolism of skel-
etal muscles between high stimulation and low
stimulation frequency. A recent study (50) showed
that during muscle contraction induced by electri-
cal stimulation, low frequency stimulation at 30 Hz was
useful to maintain a low energy level and intracellular
pH, whereas the energy level and intracellular pH
during high frequency stimulation at 100 Hz recov-
ered rapidly to values before stimulation, after they
dropped to a minimum. Further studies are required
to clarify the therapeutic effects on muscle mass
and muscle strength using electrical stimulation. In
the near future, we will select the stimulation fre-
quency by considering and understanding the dif-
ference of therapeutic effect on skeletal muscles.
4. Pharmacologic treatments
During prolonged bed rest, the main cause of dis-
use osteoporosis is loss or reduction of mechani-
cal stress on bones to accelerate bone resorption.
From the viewpoint of the mechanism of disuse
osteoporosis, pharmacologic intervention using
antiresorptive agents (i.e. bisphosphonate (51),
calcitonin (52), vitamin K2 (53)) are recommended.
Bisphosphonates strongly inhibit bone resorption,
and have been administered to treat primary osteoporosis
and secondary osteoporosis, includingdisuseosteoporosis,
all over the world. Bisphosphonates contain two
phosphonate groups attached to a single carbon
atom, forming a “P-C-P” structure. The 3rd genera-
tion bisphosphonates are 10,000 times more active
than the 1st generation bisphosphonate etidronate
(54). Kedlaya et al . (55) showed that a single dose
of pamidronate effectively improved hypercalcemia
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induced by immobilization in patients with para-
plegia. An experimental study, on the other hand,
showed that clodronate increased bone ash weight,
maximal torque capacity, maximal angle capacity
and rigidity of the bone atrophied by immobiliza-
tion (56). It is certain that bisphosphonates are use-
ful to treat disuse osteoporosis and hypercalcemia
induced by immobilization. Markers of bone resorption
are good indices of the effects of the bisphosphonates
on disuse osteoporosis.
At present, bisphosphonates are being adminis-
tered to treat disuse osteoporosis in patients with
RA. Cantatore et al . (57) studied the effects of oral
alendronate on bone metabolism and parameters
of osteoclastic activity in early RA, and showed that
alendronate decreased interleukin-1, interleukin-6,
tumor necrosis factor-alpha, and beta2 microglobulin
associated with a decrease of erythrocyte sedimen-
tation rate and C-reactive protein. These results
suggest that alendronate may have an antiarthritic
effect. Alendronate may become the drug of choice
to treat RA and RA-induced generalized osteoporosis
as well as disuse osteoporosis.
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